OncoRes Raises $27m for Breast Cancer Tool

OncoRes Medical: First Patient Treated in MARGIN Clinical Study

WA’s OncoRes secures nearly $30m in funding for breast cancer detection probe

OncoRes Medical Raises Funding to Advance Elora Clinical Development

WA Cancer Fighter's $30m Cash Injection

Daniel Firth leads data and AI programs at OncoRes, overseeing a team of software developers, engineers, and data scientists. With a background spanning physics, mathematics, data science and consulting, he brings a rare blend of technical expertise and practical problem-solving to one of the most challenging frontiers - applying AI and computer vision in regulated medical environments. #OncoRes #innovation #medtech #leadership #AI #medicalinnovation #breastcancer #technology

Imogen is an experienced clinical researcher with a diverse background in cancer care, business development and biomedical research. She...

UWA invests $1m in OncoRes Medical, as company enters final stretch of FDA pitch

Georgina has been with OncoRes Medical since the early days, supporting the team through significant growth and expansion. Her role has...

27 March 2025 / Tracy Vo / Channel 9 News OncoRes Medical was featured on Nine News, showcasing our groundbreaking Elora device that...

Dr Wes Allen is OncoRes Medical’s Product Manager. He was part of the Company’s founding team, responsible for developing the system used...

Meet Dr. Bridget Ryan, OncoRes' Deputy Chief Medical Officer. Her dedication to improving breast cancer outcomes is underpinned by a...

2024 is shaping up to be a pivotal year for OncoRes Medical. As we advance our innovative technology, generating robust evidence that...

Monday, 25 March 2024 / Tom Rabe / Australian Financial Review Source: Image from Australian Financial Review OncoRes Medical has been featured in the Australian Financial Review in an article by journalist Tom Rabe titled ‘More than mining’: WA med-tech sector message to local investors’. The article highlights how OncoRes’ cutting-edge imaging technology is reshaping cancer treatment, and propelling WA's healthcare sector into the spotlight. Here’s an excerpt: ‘O

Friday, 18 August 2023 / Katina Curtis / The West Australian Excerpt from article: OncoRes boss Katharine Giles says raw materials - resources and ideas - have historically been shipped out of WA far too early. She wants to change that. Dr Giles has been appointed to the inaugural board of the National Reconstruction Fund, the Federal Government's vehicle for financing local manufacturing expansion and strengthening domestic supply chains. This article was first published

Tuesday, 18 July 2023 OncoRes Medical, a Perth-based medical device company, has secured $3M grant funding from the Cook Government's...

Wednesday, 2 November 2022 Quantitative Micro-Elastography (QME) Imaging System published in peer reviewed Cancer Research OncoRes...

24 May 2022 / Adam Ang / MobiHealth News The company develops a breakthrough device for detecting residual cancer tissues. OncoRes medical device. (Supplied) Excerpt from article: Perth-based medical device firm OncoRes Medical has bagged $12.5 million in funding to support its upcoming clinical trials. It recently scored $9.5 million in a Series A2 funding co-led by VC Brandon Capital and Future of Healthcare Fund by Australian Unity. A separate $3 million funding was se

Wednesday, 18 May 2022 / Liam Wignell / Startup News OncoRes Medical chief commercial officer Simon Graindorge with CEO Katharine Giles. Image supplied. Excerpt from article: Perth-based OncoRes Medical has announced $12.5 million in funding to advance its innovative imaging system that facilities real-time tumour assessment to assist surgeons in identifying and removing cancerous tissue such as breast cancer. Australian and New Zealand VC Brandon Capital, manager of the

Wednesday, 18 May 2022 OncoRes Team. Photo by Rob Johnson. OncoRes Medical’s imaging system may be a game-changer for breast cancer...